INDP
Indaptus Therapeutics Inc
NASDAQ: INDP · HEALTHCARE · BIOTECHNOLOGY
$2.80
-4.11% today
Updated 2026-04-30
Market cap
$7.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-21.58
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Indaptus Therapeutics Inc (INDP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-588.00%
ROA
-148.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-5.36M | — | — | — |
| 2009 | — | $-3.94M | — | — | — |
| 2010 | — | $-5.42M | — | — | — |
| 2011 | — | $-7.58M | — | — | — |
| 2012 | — | $-5.18M | — | — | — |
| 2013 | — | $-5.09M | — | — | — |
| 2014 | — | $-5.69M | — | — | — |
| 2015 | — | $-7.18M | — | — | — |
| 2016 | — | $-13.36M | — | — | — |
| 2017 | — | $-28.91M | — | — | — |
| 2018 | — | $-43.54M | — | — | — |
| 2019 | — | $-47.60M | — | — | — |
| 2020 | $0.00 | $-3.58M | — | — | — |
| 2021 | $0.00 | $-7.71M | — | — | — |
| 2022 | $0.00 | $-14.32M | — | — | — |
| 2023 | $0.00 | $-15.42M | — | — | — |
| 2024 | $0.00 | $-15.02M | — | — | — |
| 2025 | $0.00 | $-20.85M | — | — | — |